Research a compound stack end to end — a structured protocol scaffold, how VialTalk researchers actually combine these compounds, receptor conflicts, and live COA-verified prices. Add 1–5 compounds.
Research signals
Redundancy, true conflicts, and dangerous additive effects
Review advised
No documented conflicts — some notes to review
Receptor activity map
| Receptor | AOD-9604 | Glutathione | Thymosin al… | KPV |
|---|---|---|---|---|
| GH C-terminal fragment / lipolytic mechanism | ||||
| Glutathione peroxidase substrate / redox buffer (GSH system) | ||||
| Reactive oxygen species scavenging (direct radical scavenging) | ||||
| Toll-like receptor signaling / T-cell maturation / dendritic-cell axis | ||||
| Galectin-1 (Gal-1) | ||||
| Phosphatidylserine membrane / membrane signaling cascade | ||||
| AKT/mTORC1/PPARγ/FAS signaling axis | ||||
| Angiotensin-converting enzyme (ACE) |
+1 more receptor
A structured, research-grounded protocol for this stack
Sign in to build a structured research protocol scaffold for Thymosin alpha-1 + AOD-9604 + Glutathione + KPV — phases, per-compound parameters, endpoints and washout, grounded in documented research.
What VialTalk researchers actually run
No researchers have logged this exact combination yet — yours could be the first.
Researchers are also adding
Best price for each compound today
Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.
For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.